Xenon Pharmaceuticals (XENE) Financials

$58.65

$-0.15 (-0.26%)

As on 11-Sep-2026 16:00EDT

Market cap

$5,786 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

4.7

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-279.12	-181.39	-145.33	-98.43	-69.50
Cash Flow from Investing Activities	--	218.00	165.00	-117.17	-296.00	-246.77
Cash from Financing Activities	--	117.11	12.13	353.52	278.47	447.54
Net Cash Inflow / Outflow	--	--	--	--	-115.96	131.27

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-4.76	-4.36	-2.99	-2.61	-1.91	-1.91
Cash EPS ($)	--	-4.33	-2.96	-2.56	-1.88	-1.89
Adjusted Book Value ($)	--	7.34	9.63	13.26	10.99	13.35
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.52	-2.31	-2.08	-1.50	-1.69
Free Cash Flow per Share ($)	--	-3.53	-2.35	-2.16	-1.54	-1.74

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-51.11	-27.52	-21.83	-19.43	-21.52
ROE (%)	-44.86	-51.76	-27.85	-22.12	-19.72	-21.87
ROA (%)	-39.96	-38.87	-26.58	-21.22	-18.91	-20.73
EBIT Margin (%)	--	-4,598.59	--	--	-1,368.91	-428.45
Net Margin (%)	--	-4,612.13	--	--	-941.10	-425.42
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	-1.00	-0.49	-0.43
EBIT Growth (%)	3.41	-44.66	-11.38	-65.75	-63.49	-152.37
Net Profit Growth (%)	-47.07	-47.62	-28.48	-45.48	-58.94	-173.54
EPS Growth (%)	-34.29	-0.46	-0.15	-0.37	0.00	-1.45
Book Value Growth (%)	55.33	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-10.27	-13.11	-17.67	-20.65	-16.31
Price / Book Value	4.69	6.11	4.07	3.47	3.59	2.34
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	34.16	-8.80	-10.41	-12.33	-15.74	-9.52
Close Price ($)	60.36	44.82	39.20	46.06	39.43	31.24
High Price ($)	63.95	46.56	50.99	47.00	41.39	36.42
Low Price ($)	30.00	26.74	35.53	27.99	24.60	13.23
Market Cap ($ Cr)	5,786.22	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	0.01	0.01	0.01	0.02
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.00	0.00
Current Ratio	21.02	13.42	17.85	23.65	26.44	39.03
Quick Ratio	21.02	--	--	23.65	26.49	39.23
Interest Coverage	--	--	--	--	-23.43	-78.13

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	18.28	--	--	10.45	15.00
Asset Turnover	--	0.01	--	--	0.01	0.05
Receivable days	--	69.15	--	--	72.61	45.44
Inventory Days	--	--	0.00	-1.07	-6.48	-11.10
Payable days	--	643.10	975.05	18.63	21.26	16.61
Cash Conversion Cycle	--	--	--	--	44.87	17.72

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.